ZuvaChem, Inc

Welcome

ZuvaChem is developing biocatalysts and a biochemical process for the commercial production of polymer grade isoprene. Isoprene is primarily used in the manufacture of synthetic rubber through polymerization into cis-1,4-polyisoprene, chemically identical and functionally equivalent to natural rubber, a strategic resource in short supply. Isoprene is currently made from a five carbon side stream from the cracking and refining of petroleum. Isoprene is also biologically synthesized in nature by certain plants in response to transient thermal stress. This natural biochemical pathway can be exploited by ZuvaChem through a range of industrial microbes using a combination of genetic engineering and chemical engineering technologies to produce isoprene.

    login email password cancernetwork members: login | register         cancernetwork searchmedica medline drugs powered by searchmedica   publications news podcasts topics blogs nurses patients jobs conferences cme supplements   home » oncology. Vol. buying viagra online boots 11 no. viagra low cost 4 pages: 1  2   next   an overview of adenocarcinoma of the small intestine by alfred i. viagra walmart price Neugut, md, phd, department of clinical medicine and public health, michael r. what happens if i take viagra and viagra together Marvin, md, john a. Chabot, md, deparment of surgery, vincent a. viagra for women for sale uk Rella, md , department of medicine college of physicians and surgeons, columbia university , new york | april 1, 1997 even though the small intestine contains 90% of the gastrointestinal tract mucosa and is located between the stomach and large intestine, two organs with a high cancer incidence, adenocarcinoma of the small intestine is 1/50th as common as adenocarcinoma of the large bowel. viagra no prescription In several other respects, small-intestinal adenocarcinoma resembles large bowel adenocarcinoma; eg, it arises from adenomatous polyps, co-occurs in the same individuals, and has a similar pattern of incidence rates by country. Small-intestinal adenocarcinoma is diagnosed prior to surgery in only about 50% of cases and often occurs in conjunction with small bowel obstruction. order viagra canada The mainstay of treatment is surgery; prognosis depends on stage at presentation. Little is known about the use of radiotherapy and chemotherapy in this malignancy, but most physicians utilize therapeutic strategies modeled on the management of large-intestinal adenocarcinoma. viagra walmart price Clarification of the reason for the low incidence of small-intestinal adenocarcinoma could lead to new interventions for the prevention of colorectal cancer. viagra online [oncology 11(4):529-536, 1997] introduction cancer of the small intestine is not among the top 25 cancers in the united states. buy viagra Approximately 3,600 new cases of small-bowel cancer are diagnosed each year in the united states, with almost 1,000 deaths. cheap viagra pills online [1] the rarity of small-bowel cancer is particularly surprising given the location of the small intestine between two organs with relatively high cancer incidence, ie, the stomach and the colon. Indeed, the small intestine contains 75% of the length of the alimentary tract, with 90% of its surface mucosal area, and yet carcinoma is rare in this organ. It is precisely this relative paucity that makes the tumor so intriguing. Little has been published about the clinical features and management of small bowel cancer. price of viagra 5mg Although there are four major histologic subtypes of small intestinal cancer (ie, adenocarcinoma, malignant carcinoid, lymphoma, and leiomyosar. ZuvaChem’s technology, for which the company has obtained feasibility data and filed patent applications, will enable renewable production of pure isoprene at a price competitive with, or lower than, petrochemically derived isoprene. ZuvaChem’s technology therefore has the potential of capturing a significant portion of the large and growing markets (>$20 billion in total) for rubber and isoprene.

Since its founding in November 2008, ZuvaChem has advanced these developments through a series of research contracts and sponsored research agreements while operated as a virtual company. ZuvaChem is an Acidophil LLC company.